EDAP TMS SA Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
EDAP TMS SA (FOCL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of 3.09 EUR/shares for the 12-month period ending 2024-12-31, per its 20-F filed 2025-03-27.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-03-25
EUR/shares
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | 3.09 EUR/shares 20-F · filed 2025-03-27 | ||
| 2023-12-31 | 4.95 EUR/shares 20-F · filed 2025-03-27 | ||
| 2022-12-31 | 4.70 EUR/shares 20-F · filed 2023-04-07 | 4.33 EUR/shares 20-F · filed 2025-03-27 | |
| 2022-11-30 | 5.05 EUR/shares 20-F · filed 2023-04-07 | ||
| 2022-05-31 | 3.13 EUR/shares 20-F · filed 2023-04-07 | ||
| 2021-12-31 | 2.37 EUR/shares 20-F · filed 2024-03-28 | ||
| 2021-11-30 | 2.29 EUR/shares 20-F · filed 2023-04-07 | ||
| 2021-06-30 | 2.37 EUR/shares 20-F · filed 2023-04-07 | ||
| 2020-12-31 | 0.00 EUR/shares 20-F · filed 2021-04-07 | ||
| 2019-12-31 | 1.93 EUR/shares 20-F · filed 2022-04-08 | ||
| 2018-12-31 | 1.33 EUR/shares 20-F · filed 2021-04-07 | ||
| 2017-12-31 | 1.29 EUR/shares 20-F · filed 2020-04-16 | 1.67 EUR/shares 20-F · filed 2018-04-30 | |
| 2016-12-31 | 1.67 EUR/shares 20-F · filed 2019-04-12 |
USD/shares
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2024-12-31 | $0.99 10-K · filed 2026-03-25 |
| 2023-12-31 | $3.35 10-K · filed 2026-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B |